• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃和小肠的辐射剂量-体积效应。

Radiation dose-volume effects in the stomach and small bowel.

机构信息

Department of Radiation Oncology, University of Colorado-Denver School of Medicine, Aurora, CO 80045, USA.

出版信息

Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S101-7. doi: 10.1016/j.ijrobp.2009.05.071.

DOI:10.1016/j.ijrobp.2009.05.071
PMID:20171503
Abstract

Published data suggest that the risk of moderately severe (>or=Grade 3) radiation-induced acute small-bowel toxicity can be predicted with a threshold model whereby for a given dose level, D, if the volume receiving that dose or greater (VD) exceeds a threshold quantity, the risk of toxicity escalates. Estimates of VD depend on the means of structure segmenting (e.g., V15 = 120 cc if individual bowel loops are outlined or V45 = 195 cc if entire peritoneal potential space of bowel is outlined). A similar predictive model of acute toxicity is not available for stomach. Late small-bowel/stomach toxicity is likely related to maximum dose and/or volume threshold parameters qualitatively similar to those related to acute toxicity risk. Concurrent chemotherapy has been associated with a higher risk of acute toxicity, and a history of abdominal surgery has been associated with a higher risk of late toxicity.

摘要

已发表的数据表明,中重度(>=3 级)放射性急性小肠毒性的风险可以通过阈值模型进行预测,根据该模型,对于给定的剂量水平 D,如果接受该剂量或更高剂量的体积(VD)超过阈值量,则毒性风险会增加。VD 的估计取决于结构分段的方法(例如,如果单独勾画肠袢,则 V15=120cc,如果勾画整个腹膜腔肠,则 V45=195cc)。对于胃,目前还没有类似的急性毒性预测模型。迟发性小肠/胃毒性可能与最大剂量和/或体积阈值参数有关,这些参数与急性毒性风险的参数相似。同期化疗与急性毒性风险增加相关,腹部手术史与迟发性毒性风险增加相关。

相似文献

1
Radiation dose-volume effects in the stomach and small bowel.胃和小肠的辐射剂量-体积效应。
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S101-7. doi: 10.1016/j.ijrobp.2009.05.071.
2
Predictors of grade 3 or higher late bowel toxicity in patients undergoing pelvic radiation for cervical cancer: results from a prospective study.接受宫颈癌盆腔放疗的患者发生 3 级或更高级别的迟发性肠道毒性的预测因素:一项前瞻性研究的结果。
Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):630-5. doi: 10.1016/j.ijrobp.2013.11.214.
3
Small bowel dose parameters predicting grade ≥ 3 acute toxicity in rectal cancer patients treated with neoadjuvant chemoradiation: an independent validation study comparing peritoneal space versus small bowel loop contouring techniques.对比腹腔空间勾画与小肠袢勾画技术,预测新辅助放化疗直肠癌患者发生 ≥3 级急性毒性的小肠剂量学参数:一项独立验证研究。
Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1225-31. doi: 10.1016/j.ijrobp.2012.09.036. Epub 2012 Nov 20.
4
Dose-volume histogram predictors of chronic gastrointestinal complications after radical hysterectomy and postoperative concurrent nedaplatin-based chemoradiation therapy for early-stage cervical cancer.根治性子宫切除术及术后顺铂类为基础的同期放化疗治疗早期宫颈癌后慢性胃肠道并发症的剂量-体积直方图预测因素。
Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):728-34. doi: 10.1016/j.ijrobp.2012.05.021. Epub 2012 Jun 23.
5
Predicting grade 3 acute diarrhea during radiation therapy for rectal cancer using a cutoff-dose logistic regression normal tissue complication probability model.使用截断剂量逻辑回归正常组织并发症概率模型预测直肠癌放疗期间的 3 级急性腹泻。
Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):66-72. doi: 10.1016/j.ijrobp.2009.04.048. Epub 2009 Aug 6.
6
Visceral adipose ratio as a novel predictor for acute bowel toxicity in patients receiving pelvic radiation: Preliminary dosimetric analysis and clinical validation.内脏脂肪比率作为盆腔放疗患者急性肠道毒性的新型预测指标:初步剂量学分析与临床验证
J Med Imaging Radiat Oncol. 2019 Jun;63(3):408-414. doi: 10.1111/1754-9485.12863. Epub 2019 Mar 4.
7
Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer.局部晚期直肠癌患者在基于5-氟尿嘧啶和奥沙利铂的放化疗期间,肠炎与肠道受照射体积之间的剂量-体积关系。
Acta Oncol. 2007;46(7):937-44. doi: 10.1080/02841860701317873.
8
A systematic review of dose-volume predictors and constraints for late bowel toxicity following pelvic radiotherapy.盆腔放疗后迟发性肠毒性的剂量-体积预测因子和限制因素的系统评价。
Radiat Oncol. 2019 Apr 3;14(1):57. doi: 10.1186/s13014-019-1262-8.
9
Late effects of radiation therapy on the gastrointestinal tract.放射治疗对胃肠道的远期效应。
Int J Radiat Oncol Biol Phys. 1995 Mar 30;31(5):1213-36. doi: 10.1016/0360-3016(94)00419-L.
10
[Normal tissue tolerance to external beam radiation therapy: small bowel].[正常组织对体外放射治疗的耐受性:小肠]
Cancer Radiother. 2010 Jul;14(4-5):350-3. doi: 10.1016/j.canrad.2010.03.013. Epub 2010 Jul 3.

引用本文的文献

1
Effect of pyrogallol nanocomposite on miRNA and its associated pathways during radiation-induced toxicity in small intestine of irradiated Balb/C mice.连苯三酚纳米复合材料对受辐照Balb/C小鼠小肠辐射诱导毒性过程中miRNA及其相关通路的影响。
Med Oncol. 2025 Aug 30;42(10):457. doi: 10.1007/s12032-025-02989-7.
2
Case Report: Cadonilimab plus anlotinib with radiotherapy for lung adenocarcinoma with pancreatic metastasis in later-line therapy.病例报告:卡度尼利单抗联合安罗替尼并放疗用于晚期肺腺癌伴胰腺转移的后线治疗
Front Immunol. 2025 Jul 18;16:1610710. doi: 10.3389/fimmu.2025.1610710. eCollection 2025.
3
STRONG II trial: stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma - a single-arm multicentre phase II study.
STRONG II试验:不可切除的肝门部胆管癌化疗后立体定向体部放射治疗——一项单臂多中心II期研究。
BMJ Open. 2025 Jul 16;15(7):e097545. doi: 10.1136/bmjopen-2024-097545.
4
Dosimetric Advantage of Scanning Beam Proton Therapy in Gynecologic Patients Receiving Adjuvant Radiotherapy.扫描束质子治疗在接受辅助放疗的妇科患者中的剂量学优势。
Cancers (Basel). 2025 Jun 17;17(12):2010. doi: 10.3390/cancers17122010.
5
A Case of Stereotactic Body Radiotherapy for Inoperable Intraductal Papillary Neoplasm of the Bile Duct.一例不可切除胆管内乳头状肿瘤的立体定向体部放射治疗病例
Cureus. 2025 Mar 20;17(3):e80916. doi: 10.7759/cureus.80916. eCollection 2025 Mar.
6
Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients.肠道的低剂量照射可提高转移性癌症患者中PD-L1阻断疗法的疗效。
Cancer Cell. 2025 Mar 10;43(3):361-379.e10. doi: 10.1016/j.ccell.2025.02.010.
7
Towards Personalized Radiotherapy in Pelvic Cancer: Patient-Related Risk Factors for Late Radiation Toxicity.迈向盆腔癌的个性化放疗:晚期放射毒性的患者相关风险因素
Curr Oncol. 2025 Jan 17;32(1):47. doi: 10.3390/curroncol32010047.
8
Predicting High-Grade Acute Urinary Toxicity and Lower Gastrointestinal Toxicity After Postoperative Volumetric Modulated Arc Therapy for Cervical and Endometrial Cancer Using a Normal Tissue Complication Probability Model.使用正常组织并发症概率模型预测宫颈癌和子宫内膜癌术后容积调强弧形放疗后的高级别急性泌尿系统毒性和下消化道毒性。
Curr Oncol. 2025 Jan 1;32(1):26. doi: 10.3390/curroncol32010026.
9
Comparing robust proton versus online adaptive photon radiotherapy for short-course treatment of rectal cancer.比较稳健质子放疗与在线自适应光子放疗用于直肠癌短程治疗的效果
Phys Imaging Radiat Oncol. 2024 Nov 2;32:100663. doi: 10.1016/j.phro.2024.100663. eCollection 2024 Oct.
10
Association between rheumatoid arthritis and risk of radiotherapy toxicity: a systematic review.类风湿性关节炎与放疗毒性风险之间的关联:一项系统综述。
BMJ Oncol. 2024 Jan;3(1). doi: 10.1136/bmjonc-2024-000407. Epub 2024 Jul 16.